Clinical Trial Update: First-line Intraperitoneal Cisplatin and Etoposide Chemotherapy for Ovarian Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating first-line intraperitoneal cisplatin and etoposide for bulky stage IIIC/IV epithelial ovarian cancer and related peritoneal cancers; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Platinol (cisplatin)
• VePesid (etoposide)

Snippet

Sponsor: Shanghai Gynecologic Oncology Group | Conditions: Bulky Stage IIIC and IV Epithelial Ovarian Cancer, Fallopian Tube Cancer | Phase 2 | Status: COMPLETED